Ledger.Open graph →
SEC Form D · Amendment · filed August 15, 2017

ReCor Medical, Inc

Offering
$22.0M
Sold
$22.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PALO ALTO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Matthew M. Carlstedt · Indianapolis, INDirectorRon Zboril · Austin, TXExecRobert Macpherson · VANCOUVER, British Columbia, CanadaExec · DirectorJames Livingstone · VANCOUVER, British Columbia, CanadaDirectorJeffrey Charbonneau · VANCOUVER, British Columbia, CanadaDirectorChristopher M. Meekins · Grand Cayman, Cayman IslandsExec · DirectorWilliam M. Carlstedt · Indianapolis, INDirectorJulie T. Thomas · Cincinnati, OHExecTrishield Partners LLC · New York, NYExec · DirectorTrishield Capital Management LLC · New York, NYDirectorSteve C. Le Page · ST PETER PORT, Y7DirectorMinor Myers · New York, NYDirectorPeter W. Kim · STAMFORD, CTDirectorBlake E. Robbins · Bellevue, WAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗